Nanjing Vishee Medical Technology Co (SHSE:688580) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Change In Receivables?

Nanjing Vishee Medical Technology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Nanjing Vishee Medical Technology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Nanjing Vishee Medical Technology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-21.8 Mil. It means Nanjing Vishee Medical Technology Co's Accounts Receivable increased by ¥21.8 Mil from Dec. 2022 to Dec. 2023 .

Nanjing Vishee Medical Technology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥36.7 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Nanjing Vishee Medical Technology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 38.23.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nanjing Vishee Medical Technology Co's liquidation value for the three months ended in Mar. 2024 was ¥1,015.2 Mil.

Nanjing Vishee Medical Technology Co Change In Receivables Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Change In Receivables Chart

Nanjing Vishee Medical Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-2.48

-15.90

-13.14

7.32

-21.77

Nanjing Vishee Medical Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Nanjing Vishee Medical Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Nanjing Vishee Medical Technology Co (SHSE:688580) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nanjing Vishee Medical Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	36.73	/	87.67	*	91
=	38.23

2. In Ben Graham's calculation of liquidation value, Nanjing Vishee Medical Technology Co's accounts receivable are only considered to be worth 75% of book value:

Nanjing Vishee Medical Technology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1114.688	-	147.66	+	0.75 * 36.73	+	0.5 * 41.274
=	1,015.2

Nanjing Vishee Medical Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012

Website

http://www.vishee.com

Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.

Executives

Huang He	Senior management, core technical personnel
Chou Kai	Senior management, core technical personnel
Zhong Yi Qun	senior management
Chen Li Li	Directors, senior managers
Zhang Hui	senior management
Gao Fei	Core technical personnel
Lian Qing Ming	Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines